Kit is essential for PMA-inflammation-induced mast-cell accumulation in the skin

Claudia Waskow1, Susanne Bartels, Susan M Schlenner

  • 1Institute for Immunology, University of Ulm, Ulm, Germany.

Blood
|March 1, 2007
PubMed

Insights

Skin inflammation involves mast cells, but signals controlling their numbers are unclear. This study shows Kit signaling and lymphocytes regulate mast cell accumulation in inflamed skin.

Area of Science:

  • Immunology
  • Dermatology
  • Cell Biology

Background:

  • Cutaneous mast cells play a key role in skin inflammation.
  • The precise signals regulating mast cell numbers in healthy and inflamed skin remain incompletely understood.
  • Mast cell development is critically dependent on the receptor tyrosine kinase Kit.

Purpose of the Study:

  • To investigate the role of Kit signaling in inflammation-driven mast cell accumulation in the skin.
  • To determine whether lymphocytes contribute to mast cell compartment regulation under limiting Kit signaling.

Main Methods:

  • Utilized viable Kit-null (Kit(W/W)) and hypomorphic (Kit(W/Wv)) mice.
  • Induced chronic skin inflammation using phorbol-12-myristate-13-acetate (PMA).
  • Assessed mast cell numbers in inflamed skin and employed reconstitution experiments with lymphocyte-deficient mice.

Main Results:

  • Kit signaling is essential for mast cell accumulation in chronically inflamed skin.
  • Mast cell accumulation in inflamed skin was significantly reduced in Kit(W/Wv) mice lacking mature lymphocytes (T, B, and NK cells).
  • Lymphocytes play a role in regulating mast cell numbers when Kit signaling is limited.

Conclusions:

  • Inflammation-induced cutaneous mast cell accumulation is dependent on the strength of Kit signaling.
  • Under conditions of limited Kit signaling, adaptive immune cells, specifically lymphocytes, are crucial for regulating mast cell populations in the skin.